Abstract
The diagnostic imaging contributes significantly to the diagnosis and management of sarcoidosis. Imaging techniques are widely employed in the assessment of thoracic and extra-thoracic involvement from sarcoidosis. For the diagnosis of sarcoidosis, chest radiograph has been the cornerstone of sarcoidosis since 1961, when Scadding proposed a standardized staging system. Currently, computed tomography (CT) represents the reference standard for the assessment of both mediastinal lymph nodes and pulmonary findings. In particular, high-resolution computed tomography (HRCT) is more accurate compared to chest radiography for the detection of subtle parenchymal involvement, and provides comprehensive overview of anatomical detail and abnormalities of lung structures. Notably, HRCT allows for accurate differentiation between reversible and irreversible lung disease, which is cornerstone of prognostication. Radionuclide imaging (gallium-67 and 18F-fluorodeoxyglucose) provides information about activity of the disease and is also useful for diagnostic workup of patients with unexplained persistent disabling symptoms. Magnetic resonance is sensitive for the detection of sarcoidosis granulomata within myocardium, thus providing detailed roadmap for biopsy. For the management of sarcoidosis, CT is of paramount importance in the detection and differential of most common complications, such as vascular disease and suspicious nodular lesions. Conversely, the role of CT in the follow-up of asymptomatic subjects is still under debate. This review focuses on the role of diagnostic imaging in the diagnosis and follow-up of sarcoidosis.
Similar content being viewed by others
References
Joint Statement of the American Thoracic Society (ATS), The European Respiratory Society (ERS) The World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee (1999) Statement on sarcoidosis. Am J Resp Crit Care Med 160:736–55
Mana J, Gomez-Vaquero C, Montero A et al (1999) Lofgren’s syndrome revisited: a study of 186 patients. Am J Med 107:240–245
Spagnolo P, Sverzellati N, Wells AU, Hansell DM (2014) Imaging aspects of the diagnosis of sarcoidosis. Eur Radiol 24:807–816
Keijsers RG, van den Heuvel DA, Grutters JC (2013) Imaging the inflammatory activity of sarcoidosis. Eur Respir J 41:743–751
Schatka I, Bengel FM (2014) Advanced imaging of cardiac sarcoidosis. J Nucl Med 55:99–106
Baughman RP, Teirstein AS, Judson MA et al (2001) Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 164:1885–1889
Nunes H, Brillet PY, Valeyre D, Brauner MW, Wells AU (2007) Imaging in sarcoidosis. Semin Respir Crit Care Med 28:102–120
Gumustas S, Inan N, Akansel G, Basyigit I, Ciftci E (2013) Differentiation of lymphoma versus sarcoidosis in the setting of mediastinal-hilar lymphadenopathy: assessment with diffusion-weighted MR imaging. Sarcoid, Vascul, Diffuse Lung Dis Offic J WASOG / World Assoc Sarcoid Other Granul Disord 30:52–59
Nishino M, Lee KS, Itoh H, Hatabu H (2010) The spectrum of pulmonary sarcoidosis: variations of high-resolution CT findings and clues for specific diagnosis. Eur J Radiol 73:66–73
Valeyre D, Nunes H, Bernaudin JF (2014) Advanced pulmonary sarcoidosis. Curr Opin Pulm Med 20:488–495
Rockoff SD, Rohatgi PK (1985) Unusual manifestations of thoracic sarcoidosis. AJR Am J Roentgenol 144:513–528
Conant EF, Glickstein MF, Mahar P, Miller WT (1988) Pulmonary sarcoidosis in the older patient: conventional radiographic features. Radiology 169:315–319
Scadding JG (1961) Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J 2:1165–1172
DeRemee RA (1983) The roentgenographic staging of sarcoidosis. Historic and contemporary perspectives. Chest 83:128–133
Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153–2165
Muers MF, Middleton WG, Gibson GJ et al (1997) A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment. Sarcoid, Vascul, Diffuse Lung Dis Offic J WASOG / World Assoc Sarcoid Other Granul Disord 14:46–56
Greco FG, Spagnolo P, Muri M et al (2014) The value of chest radiograph and computed tomography in pulmonary sarcoidosis. Sarcoid, Vascul, Diffuse Lung Dis Offic J WASOG / World Assoc Sarcoid Other Granul Disord 31:108–116
Keir G, Wells AU (2010) Assessing pulmonary disease and response to therapy: which test? Semin Respir Crit Care Med 31:409–418
de Boer S, Milne DG, Zeng I, Wilsher ML (2009) Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis? Thorax 64:436–439
Eckardt J, Olsen KE, Jorgensen OD, Licht PB (2010) Minimally invasive diagnosis of sarcoidosis by EBUS when conventional diagnostics fail. Sarcoidosis Vasc Diffuse Lung Dis 27:43–48
Criado E, Sanchez M, Ramirez J et al (2010) Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiograph Rev Pub Radiol Soc North Am Inc 30:1567–1586
Hawtin KE, Roddie ME, Mauri FA, Copley SJ (2010) Pulmonary sarcoidosis: the ‘Great Pretender’. Clin Radiol 65:642–650
Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A (1994) Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 191:675–680
Leung AN, Brauner MW, Caillat-Vigneron N, Valeyre D, Grenier P (1998) Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay. J Comput Assist Tomogr 22:229–234
Brauner MW, Lenoir S, Grenier P, Cluzel P, Battesti JP, Valeyre D (1992) Pulmonary sarcoidosis: CT assessment of lesion reversibility. Radiology 182:349–354
Abehsera M, Valeyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW (2000) Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 174:1751–1757
Walsh SL, Wells AU, Sverzellati N et al (2014) An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. Lancet Respirator Med 2:123–130
Kohn H, Klech H, Mostbeck A, Kummer F (1982) 67Ga scanning for assessment of disease activity and therapy decisions in pulmonary sarcoidosis in comparison to chest radiography, serum ACE and blood T-lymphocytes. Eur J Nucl Med 7:413–416
Mostard RL, van Kroonenburgh MJ, Drent M (2013) The role of the PET scan in the management of sarcoidosis. Curr Opin Pulm Med 19:538–544
Mostard RL, Verschakelen JA, van Kroonenburgh MJ et al (2013) Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis. Respir Med 107:439–447
Cremers JP, Van Kroonenburgh MJ, Mostard RL et al (2014) Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population. Sarcoid, Vascul, Diffuse Lung Dis Offic J WASOG / World Assoc Sarcoid Other Granul Disord 31:37–45
Sobic-Saranovic D, Grozdic I, Videnovic-Ivanov J et al (2012) The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis. J Nuclear Med Offic Pub Soc Nuclear Med 53:1543–1549
Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC (2007) Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 132:1949–1953
Giesbrandt KJ, Bolan CW, Shapiro BP, Edwards WD, Mergo PJ (2013) Diffuse diseases of the myocardium: MRI-pathologic review of cardiomyopathies with dilatation. AJR Am J Roentgenol 200:W274–W282
Kim JS, Judson MA, Donnino R et al (2009) Cardiac sarcoidosis. Am Heart J 157:9–21
Soussan M, Brillet PY, Nunes H et al (2013) Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nuclear Cardiol Offic Pub Am Soc Nuclear Cardiol 20:120–127
Chung JH, Cox CW, Forssen AV, Biederer J, Puderbach M, Lynch DA (2014) The dark lymph node sign on magnetic resonance imaging: a novel finding in patients with sarcoidosis. J Thorac Imaging 29:125–129
Handa T, Nagai S, Miki S et al (2006) Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis. Chest 129:1246–1252
Resten A, Maitre S, Humbert M et al (2004) Pulmonary hypertension: CT of the chest in pulmonary venoocclusive disease. AJR Am J Roentgenol 183:65–70
Matthay RA, Schwarz MI, Ellis JH Jr et al (1981) Pulmonary artery hypertension in chronic obstructive pulmonary disease: determination by chest radiography. Invest Radiol 16:95–100
Swigris JJ, Olson AL, Huie TJ et al (2011) Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007. Chest 140:1261–1266
Sogaard KK, Svaerke C, Thomsen RW, Norgaard M (2014) Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study. Eur Respir J 45(1):269–72. doi:10.1183/09031936.00084414
Kumar S, Baghdadi S, Cale AR (2006) Concurrence of sarcoidosis and lung cancer: a diagnostic dilemma. Thorax 61:1100
Wollschlager C, Khan F (1984) Aspergillomas complicating sarcoidosis. A prospective study in 100 patients. Chest 86:585–588
Franquet T, Muller NL, Gimenez A, Guembe P, de La Torre J, Bague S (2001) Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings. Radiographics 21:825–837
Sansom HE, Baque-Juston M, Wells AU, Hansell DM (2000) Lateral cavity wall thickening as an early radiographic sign of mycetoma formation. Eur Radiol 10:387–390
Nunes H, Uzunhan Y, Gille T, Lamberto C, Valeyre D, Brillet PY (2012) Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function. Eur Respir J 40:750–765
Baughman RP, Shipley R, Desai S et al (2009) Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest 136:526–535
Zappala CJ, Desai SR, Copley SJ et al (2011) Optimal scoring of serial change on chest radiography in sarcoidosis. Sarcoid, Vascul, Diffuse Lung Dis Offic J WASOG / World Assoc Sarcoid Other Granul Disord 28:130–138
Zappala CJ, Desai SR, Copley SJ et al (2014) Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data. Chest 145:101–107
Gafa G, Sverzellati N, Bonati E et al (2012) Follow-up in pulmonary sarcoidosis: comparison between HRCT and pulmonary function tests. Radiol Med 117:968–978
Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J (2014) Sarcoidosis. Lancet 383:1155–1167
Conflict of Interest
Mario Silva, Hilario Nunes, Dominique Valeyre, and Nicola Sverzellati declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Silva, M., Nunes, H., Valeyre, D. et al. Imaging of Sarcoidosis. Clinic Rev Allerg Immunol 49, 45–53 (2015). https://doi.org/10.1007/s12016-015-8478-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12016-015-8478-7